SCHEMBL25877834

SCHEMBL25877834

CC(C)(C)c1ccc(-c2nc(-c3ccccc3)nc(C(C)(C)C)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.55
NPC1 O15118 3/20 0.55
ABCG2 Q9UNQ0 2/20 0.50
TP53 P04637 4/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
KIF11 P52732 2/20 0.44
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HDAC6 Q9UBN7 1/20 0.42
TNF P01375 1/20 0.42
NOD1 Q9Y239 1/20 0.42
XDH P47989 1/20 0.42
TNKS O95271 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
HPGD P15428 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12628221 0.92 RAB9A (0.62) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL13539895 0.92 RAB9A (0.62) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL25762601 0.92 RAB9A (0.62) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL12938318 0.90 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL19735249 0.90 L3MBTL1 (0.54) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL19735244 0.90 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL19862786 0.90 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL13539886 0.90 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL12628248 0.90 RAB9A (0.60) RAB9ANPC1ABCG2TP53SMN1; SMN2
SCHEMBL25878006 0.90 L3MBTL1 (0.54) RAB9ANPC1ABCG2TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM RAB9A 1514/4885NPC1 1759/4885ABCG2 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.